- 2020
-
Press releases - 09.06.2020
Repetitive negative thinking linked to dementia risk
Persistently engaging in negative thinking patterns may raise the risk of Alzheimer’s disease, finds a new UCL-led study.
-
Press releases - 08.06.2020
Eliminating Senescent Cells Is Not the Answer to a Long and Healthy Life
Until now considered highly promising in the fight against aging, the therapeutic strategy of eliminating the senescent cells that accumulate in the body is being challenged by the team of Dmitry Bulavin, Inserm researcher at the Institute for Research on Cancer and Aging of Nice (Inserm/CNRS/Université Côte d’Azur).
-
Press releases - 05.06.2020
Covid-19: Publication of a prospective observational study in the journal BMJ in children with hyper-inflammatory syndrome related to Kawasaki disease
characteristics of children and adolescents hospitalized in a context of Kawasaki disease-like syndrome in a COVID-19 epidemic context, with a systemic hyper-inflammatory expression.
-
Press releases - 05.06.2020
COVID-19 and the Environment: A European Program Coordinated by Inserm gives its recommendations
Launched in 2019, the primary objective of the Health Environment Research Agenda for Europe (HERA) is to provide the European Commission with an environment, climate, and health research agenda for 2020-2030.
-
Press releases - 28.05.2020
Paris and Its Suburbs: Twice as Many Cardiac Arrests During Lockdown
Indirect consequences of the COVID-19 pandemic on the healthcare system and the management of other diseases are beginning to emerge.
-
Press releases - 28.05.2020
Tests for everyone, really?
Deconfinement is now well under way. At the heart of the system is a promise: massive testing of the population.
-
Press releases - 27.05.2020
Hydroxychloroquine and azithromycin can have a deleterious impact on the cardiovascular system
Hydroxychloroquine and azithromycin can have a damaging impact on the cardiovascular system and are a life-threatening combination, according to large analysis from a World Health Organization (WHO) database of adverse drug reactions.
-
Press releases - 26.05.2020
Inclusions in the hydroxychloroquine group of the Discovery trial are suspended.
Les inclusions dans le groupe hydroxychloroquine de l’essai Discovery sont suspendues depuis dimanche 24 mai.
-
Press releases - 20.05.2020
SARS-CoV-2: Will Summer Really Mean the End of It?
Will SARS-CoV-2 die out with the arrival of summer? With the current lifting of lockdown restrictions, some are hoping that the warm weather will herald a decrease in the R0, as is the case with other viruses whose transmission is better documented, such as those of seasonal influenza.
-
Press releases - 19.05.2020
Milestone: Inserm’s commitment to the fight against the Covid-19 pandemic
First identified in the central Chinese city of Wuhan in December 2019, the novel SARS-CoV-2 coronavirus has rapidly spread across the world, leading to the most serious pandemic in recent history.